Literature DB >> 21803008

Frequent alterations of LOH11CR2A, PIG8 and CHEK1 genes at chromosomal 11q24.1-24.2 region in breast carcinoma: clinical and prognostic implications.

Satyabrata Sinha1, Ratnesh K Singh, Nilanjana Bhattacharya, Nupur Mukherjee, Susmita Ghosh, Neyaz Alam, Anup Roy, Susanta Roychoudhury, Chinmay Kumar Panda.   

Abstract

To understand the importance of frequent deletions at chromosome 11q24.1-24.2 region in breast carcinoma, alterations (deletion/methylation) of the candidate genes LOH11CR2A, ROBO3, ROBO4, HEPACAM, PIG8 and CHEK1 located in this region were analyzed in 106 breast carcinoma samples. Among these genes, LOH11CR2A showed highest frequency of deletion (56%), followed by PIG8 (35%), CHEK1 (31%) and ROBO3/ROBO4/HEPACAM loci (28%). Comparable frequency of promoter methylation (26-35%) was observed for LOH11CR2A, CHEK1 and PIG8. Overall alterations (deletion/methylation) of these genes were in the following order: LOH11CR2A (60%) > PIG8 (46%) > CHEK1 (41%) and showed significant association with each other. Breast carcinoma samples that were estrogen/progesterone receptor negative showed significantly high deletion and overall alterations than estrogen/progesterone receptor positive samples for LOH11CR2A, CHEK1 and PIG8. The methylation and overall alteration of LOH11CR2A were significantly associated with tumor stages in breast carcinoma. However, in early/late onset and estrogen/progesterone receptor positive/negative breast carcinoma, the overall alterations of LOH11CR2A, PIG8 and CHEK1 were differentially associated with advanced stages, tumor grade and lymph node metastasis. Alterations of PIG8 and CHEK1 were significantly associated with poor prognosis in patients with early age of onset of the disease indicating significant prognostic importance. Quantitative mRNA expression analysis detected reduced expression of the genes in the order LOH11CR2A > CHEK1 > PIG8. Immunohistochemical analysis showed reduced protein expression of PIG8 and CHEK1 that was concordant with their molecular alterations. Thus, our study suggests that LOH11CR2A, PIG8 and CHEK1 are candidate tumor suppressor genes associated with breast carcinoma and have significant clinical as well as prognostic importance.
Copyright © 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21803008      PMCID: PMC5528301          DOI: 10.1016/j.molonc.2011.06.005

Source DB:  PubMed          Journal:  Mol Oncol        ISSN: 1574-7891            Impact factor:   6.603


  40 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Cloning and characterization of hepaCAM, a novel Ig-like cell adhesion molecule suppressed in human hepatocellular carcinoma.

Authors:  Mei Chung Moh; Lay Hoon Lee; Shali Shen
Journal:  J Hepatol       Date:  2005-04-07       Impact factor: 25.083

3.  Mapping of the candidate tumor suppressor genes' loci on human chromosome 3 in head and neck squamous cell carcinoma of an Indian patient population.

Authors:  S Dasgupta; N Mukherjee; S Roy; A Roy; A Sengupta; S Roychowdhury; C K Panda
Journal:  Oral Oncol       Date:  2002-01       Impact factor: 5.337

4.  Loss of heterozygosity in human breast carcinomas in the ataxia telangiectasia, Cowden disease and BRCA1 gene regions.

Authors:  F Kerangueven; F Eisinger; T Noguchi; F Allione; V Wargniez; C Eng; G Padberg; C Theillet; J Jacquemier; M Longy; H Sobol; D Birnbaum
Journal:  Oncogene       Date:  1997-01-23       Impact factor: 9.867

5.  Frequent alterations of LOH11CR2A, PIG8 and CHEK1 genes at chromosomal 11q24.1-24.2 region in breast carcinoma: clinical and prognostic implications.

Authors:  Satyabrata Sinha; Ratnesh K Singh; Nilanjana Bhattacharya; Nupur Mukherjee; Susmita Ghosh; Neyaz Alam; Anup Roy; Susanta Roychoudhury; Chinmay Kumar Panda
Journal:  Mol Oncol       Date:  2011-07-07       Impact factor: 6.603

6.  Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinoma.

Authors:  Federica Perrone; Simona Suardi; Elisa Pastore; Paola Casieri; Marta Orsenigo; Stefano Caramuta; Gianpaolo Dagrada; Marco Losa; Lisa Licitra; Paolo Bossi; Samantha Staurengo; Maria Oggionni; Laura Locati; Giulio Cantu; Massimo Squadrelli; Antonino Carbone; Marco A Pierotti; Silvana Pilotti
Journal:  Clin Cancer Res       Date:  2006-11-15       Impact factor: 12.531

7.  Risk factors according to estrogen receptor status of breast cancer patients in Trivandrum, South India.

Authors:  Subhojit Dey; Paolo Boffetta; Anitha Mathews; Paul Brennan; Amr Soliman; Aleyamma Mathew
Journal:  Int J Cancer       Date:  2009-10-01       Impact factor: 7.396

8.  Tumor suppressor function of BCSC-1 in nasopharyngeal carcinoma.

Authors:  Y Q Zhou; S L Chen; J Y Ju; L Shen; Y Liu; S Zhen; N Lv; Z G He; L P Zhu
Journal:  Cancer Sci       Date:  2009-06-24       Impact factor: 6.716

Review 9.  Current and emerging biomarkers in breast cancer: prognosis and prediction.

Authors:  Marion T Weigel; Mitch Dowsett
Journal:  Endocr Relat Cancer       Date:  2010-09-23       Impact factor: 5.678

10.  Methylation and silencing of the retinoic acid receptor-beta 2 gene in cervical cancer.

Authors:  Tatyana Ivanova; Anatolii Petrenko; Tatyana Gritsko; Svetlana Vinokourova; Ernest Eshilev; Vera Kobzeva; Fjodor Kisseljov; Natalia Kisseljova
Journal:  BMC Cancer       Date:  2002-03-21       Impact factor: 4.430

View more
  10 in total

1.  MRTFB suppresses colorectal cancer development through regulating SPDL1 and MCAM.

Authors:  Takahiro Kodama; Teresa A Marian; Hubert Lee; Michiko Kodama; Jian Li; Michael S Parmacek; Nancy A Jenkins; Neal G Copeland; Zhubo Wei
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-05       Impact factor: 11.205

2.  Overexpression of Roundabout4 predicts poor prognosis of primary glioma patients via correlating with microvessel density.

Authors:  Heng Cai; Yixue Xue; Wenjing Liu; Zhen Li; Yi Hu; Zhiqing Li; Xiuli Shang; Yunhui Liu
Journal:  J Neurooncol       Date:  2015-04-10       Impact factor: 4.130

3.  Frequent alterations of LOH11CR2A, PIG8 and CHEK1 genes at chromosomal 11q24.1-24.2 region in breast carcinoma: clinical and prognostic implications.

Authors:  Satyabrata Sinha; Ratnesh K Singh; Nilanjana Bhattacharya; Nupur Mukherjee; Susmita Ghosh; Neyaz Alam; Anup Roy; Susanta Roychoudhury; Chinmay Kumar Panda
Journal:  Mol Oncol       Date:  2011-07-07       Impact factor: 6.603

4.  Frequent alterations of SLIT2-ROBO1-CDC42 signalling pathway in breast cancer: clinicopathological correlation.

Authors:  Rittwika Bhattacharya; Nupur Mukherjee; Hemantika Dasgupta; Md Saimul Islam; Neyaz Alam; Anup Roy; Priyobrata Das; Susanta Roychoudhury; Chinmay Kumar Panda
Journal:  J Genet       Date:  2016-09       Impact factor: 1.166

5.  IMP2/p62 induces genomic instability and an aggressive hepatocellular carcinoma phenotype.

Authors:  S M Kessler; S Laggai; A Barghash; C S Schultheiss; E Lederer; M Artl; V Helms; J Haybaeck; A K Kiemer
Journal:  Cell Death Dis       Date:  2015-10-01       Impact factor: 8.469

6.  Mapping the chromatin landscape and Blimp1 transcriptional targets that regulate trophoblast differentiation.

Authors:  Andrew C Nelson; Arne W Mould; Elizabeth K Bikoff; Elizabeth J Robertson
Journal:  Sci Rep       Date:  2017-07-28       Impact factor: 4.379

7.  MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.

Authors:  Zhishuang Li; Qingyong Meng; Aifeng Pan; Xiaojuan Wu; Jingjing Cui; Yan Wang; Li Li
Journal:  Oncotarget       Date:  2017-03-21

8.  The forkhead transcription factor FOXM1 promotes endocrine resistance and invasiveness in estrogen receptor-positive breast cancer by expansion of stem-like cancer cells.

Authors:  Anna Bergamaschi; Zeynep Madak-Erdogan; Yu Jin Kim; Yoon-La Choi; Hailing Lu; Benita S Katzenellenbogen
Journal:  Breast Cancer Res       Date:  2014-09-12       Impact factor: 6.466

9.  Associations of ATR and CHEK1 single nucleotide polymorphisms with breast cancer.

Authors:  Wei-Yu Lin; Ian W Brock; Dan Connley; Helen Cramp; Rachel Tucker; Jon Slate; Malcolm W R Reed; Sabapathy P Balasubramanian; Lisa A Cannon-Albright; Nicola J Camp; Angela Cox
Journal:  PLoS One       Date:  2013-07-03       Impact factor: 3.240

10.  EI24 regulates epithelial-to-mesenchymal transition and tumor progression by suppressing TRAF2-mediated NF-κB activity.

Authors:  Jung-Min Choi; Sushil Devkota; Young Hoon Sung; Han-Woong Lee
Journal:  Oncotarget       Date:  2013-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.